Molecular characterization of an unusual non-Hodgkin's B-lymphoma cell line ("Farage") lacking the ability to produce immunoglobulin polypeptide chains
- PMID: 9172815
- DOI: 10.3109/10428199609093448
Molecular characterization of an unusual non-Hodgkin's B-lymphoma cell line ("Farage") lacking the ability to produce immunoglobulin polypeptide chains
Abstract
"Farage" is a cell line derived from a patient who had a diffuse and mixed type malignant lymphoma. In a previous study it was shown that Farage cells expressed B-cell markers, but not membrane IgM. Karyotypic analysis showed that in contrast to most follicular cell lymphomas, Farage did not have the 14;18 chromosomal translocation. In the present work Farage was further characterized by Southern and Northern blot analyses. Two rearranged heavy chain alleles and one rearranged kappa chain gene were detected. The cells expressed both mu and kappa mRNA, even though at a 3-7 fold lower level than that found in the control Daudi and DG-75 Burkitt lymphomas. Farage cells did not express the terminal deoxynucleotydyl transferase gene (TdT), nor the recombination activating genes RAG-1 and RAG-2, known as markers of the pre-B cell stage. These results show that Farage represents a mature B-cell rather than a pre-B cell. Despite the presence of C kappa and C mu RNAs, no Ig polypeptide chains were produced by Farage as judged by immunoblotting and biosynthesis labeling assays. Ig mRNAs were detected on the polysomal fraction, but at a lower level relative to Daudi cells. Our combined results suggest that in Farage cells translation of Ig mRNA is not fully blocked at the stage of translation initiation. Farage cells may express "germline" or mutated variants of Ig mRNAs. The unusual phenotype of Farage may reflect a normal as yet unknown stage of B-cell differentiation, or it may be due to an aberrant expression developed after malignant transformation.
Similar articles
-
Somatic mutations in the Ig variable region genes and expression of novel Cmu-germline transcripts in a B-lymphoma cell line ("Farage") not producing Ig polypeptide chains.Leuk Lymphoma. 1998 Aug;30(5-6):637-49. doi: 10.3109/10428199809057576. Leuk Lymphoma. 1998. PMID: 9711926
-
Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.J Immunol. 1994 Aug 15;153(4):1645-57. J Immunol. 1994. PMID: 8046237
-
Rearrangement and expression of kappa light chain genes can occur without mu heavy chain expression during differentiation of pre-B cells.Int Immunol. 1993 Dec;5(12):1609-18. doi: 10.1093/intimm/5.12.1609. Int Immunol. 1993. PMID: 8312230
-
Light chain loss and reexpression leads to idiotype switch. Surrogate light chains are probably responsible for this process.Curr Top Microbiol Immunol. 1995;194:179-86. doi: 10.1007/978-3-642-79275-5_22. Curr Top Microbiol Immunol. 1995. PMID: 7895491
-
Lymphoma stem cells: enough evidence to support their existence?Haematologica. 2010 Feb;95(2):293-302. doi: 10.3324/haematol.2009.013318. Haematologica. 2010. PMID: 20139392 Free PMC article. Review.
Cited by
-
Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.PLoS One. 2016 Apr 5;11(4):e0153069. doi: 10.1371/journal.pone.0153069. eCollection 2016. PLoS One. 2016. PMID: 27045839 Free PMC article.
-
Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis.J Clin Invest. 2022 Oct 17;132(20):e156254. doi: 10.1172/JCI156254. J Clin Invest. 2022. PMID: 36250467 Free PMC article.
-
A Multi-Color Flow Cytometric Assay for Quantifying Dinutuximab Binding to Neuroblastoma Cells in Tumor, Bone Marrow, and Blood.J Clin Med. 2023 Sep 27;12(19):6223. doi: 10.3390/jcm12196223. J Clin Med. 2023. PMID: 37834874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials